CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-22 | Fotopoulos Alexandros Chief Technical Officer | Option exercise · Restricted Stock Units | −12,500 | 37,500 | ||
| 2022-11-10 | King Simona Chief Financial Officer | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2022-11-10 | Forman Mark S Chief Medical Officer | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2022-11-10 | Cale Edgar B. GC & Corporate Secretary | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2022-11-10 | Fotopoulos Alexandros Chief Technical Officer | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2022-10-10 | Chou William Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +885,000 | 885,000 | ||
| 2022-09-19 | Toernsen Monika Maria Chief Commercial Officer | Sale | −1,681 | $1.51 | $3K | 3,319 |
| 2022-09-15 | Toernsen Monika Maria Chief Commercial Officer | Option exercise | +5,000 | 5,000 | ||
| 2022-09-15 | Toernsen Monika Maria Chief Commercial Officer | Option exercise · Restricted Stock Unit | −5,000 | 15,000 | ||
| 2022-07-05 | Kamarck Michael E. Director | Grant or award · Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2022-06-13 | Toernsen Monika Maria Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +101,000 | 101,000 | ||
| 2022-06-13 | King Simona Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +159,000 | 159,000 | ||
| 2022-06-13 | Forman Mark S Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +136,000 | 136,000 | ||
| 2022-06-13 | Cale Edgar B. Interim CEO, GC & Corp. Sec. | Grant or award · Employee Stock Option (right to buy) | +106,000 | 106,000 | ||
| 2022-06-13 | Fotopoulos Alexandros Chief Technical Officer | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-05-31 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-05-31 | Cale Edgar B. Interim CEO, GC & Corp. Sec. | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-05-27 | Goldsmith Bruce A CEO and President | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-05-26 | Woiwode Thomas Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2022-05-26 | Porter Derrell Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 |
Page 7 of 8 · 152 trades